UK approves single-dose 7.2mg Wegovy pen for obesity treatment

Prescribers can administer full weekly dose in one injection

Governance Manufacturing
OFSI ·
Change
The UK MHRA approved a single-dose 7.2mg Wegovy pen for adults with obesity, enabling one weekly injection.
Why it matters
The approval allows simplified dosing but restricts use to patients meeting BMI criteria and approved escalation protocols.
Implications
  • — Treatment simplified — adherence may improve
  • — Use restricted to criteria — prescribing controls apply

See full brief

Use 1 free preview to unlock implications, who’s affected, what to watch, and Clarify for this brief.

2 free previews left this month · Resets 1 Jul

Source
OFSI
View on OFSI
Clarify with AI

Clarify unlocks with the decision layer.

Decision prompts

Clarify with AI — Pro only

You asked:

Clarify turns any brief into answers specific to your role and exposure.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month · Founding rate, locked for life. Cancel anytime.

Start your trial to clarify this brief

You asked:

Clarify is part of Pro. Start a 14-day trial for full access to every brief, unlimited Clarify questions, and real-time alerts.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month after trial. No credit card required. Cancel anytime.

Start 14-day trial Sign in